Petrus Trust Company, Lta Edwards Lifesciences Corp Transaction History

Petrus Trust Company, Lta

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $134,960 - $172,781	1,976 Added 81.08%	4,413 $329,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $200,735 - $261,465	2,437 New	2,437 $201,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $52,776 - $81,567	-1,007 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $72,201 - $82,664	1,007 New	1,007 $235,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.